Unit

Sweet Security Raises $33 Million Series A, Upgrades Its Runtime Security Suite to Usher in a New Era for Cloud Security

Retrieved on: 
Wednesday, March 6, 2024

Without runtime visibility and insights, companies simply do not have an applicable way to manage their cloud risks. The recently discovered set of RunC vulnerabilities underscore how easily companies can be caught off guard by new cloud risks and be forced to spend days -- if not weeks -- trying to understand what happened and how to fix it.

Key Points: 
  • Sweet is also unveiling enhancements to its unified runtime platform, adding first-to-market capabilities for runtime posture enhancement and runtime non-human identity management.
  • Without runtime visibility and insights, companies simply do not have an applicable way to manage their cloud risks.
  • In August 2023, Sweet launched the first unified runtime security platform for the cloud.
  • The cloud presents significant challenges relating to non-human identities: As such, Sweet is introducing first-to-market functionality into its runtime security suite: runtime posture enhancement and runtime NHI management.

Osprey Bitcoin Trust Announces Exploration of Strategic Alternatives and Voluntary Deregistration

Retrieved on: 
Tuesday, March 5, 2024

Osprey Bitcoin Trust (OTCQX: OBTC), a Delaware statutory trust (the “Trust”), announced today that it is aware that the common units of fractional undivided beneficial interest of the Trust (the “Units”) are trading at a discount to the value of Bitcoin.

Key Points: 
  • Osprey Bitcoin Trust (OTCQX: OBTC), a Delaware statutory trust (the “Trust”), announced today that it is aware that the common units of fractional undivided beneficial interest of the Trust (the “Units”) are trading at a discount to the value of Bitcoin.
  • Osprey Funds, LLC, the sponsor of the Trust (the “Sponsor”), is currently exploring strategic alternatives to maximize unitholder value.
  • The Trust expects that the deregistration of its Units will become effective 90 days after the filing of the Form 15 with the SEC.
  • While the Units are quoted on the OTCQX, the Trust will remain subject to the OTCQX’s alternative reporting standard.

Carbeeza Inc. Closes 2nd and 3rd Tranches Unit Private Placement

Retrieved on: 
Tuesday, March 5, 2024

is pleased to announce that it has closed its previously announced non-brokered private placement (the "Private Placement") of units of the Company ("Units”).

Key Points: 
  • is pleased to announce that it has closed its previously announced non-brokered private placement (the "Private Placement") of units of the Company ("Units”).
  • Pursuant to the closing of the 2nd and 3rd Tranche Private Placement, the Company issued 6,500,000 Units at a price of $0.10 per Unit for gross proceeds of $650,000.
  • The net proceeds of the Private Placement will be used by the Company to scale up the marketing campaign, to expedite the Company's move into the United States market and for general corporate purposes.
  • Using state-of-the-art technology, Carbeeza brings the process of buying a car right to the phone, tailor-made for the consumer.

Flow Beverage Corp. Completes Additional Private Placement

Retrieved on: 
Friday, March 1, 2024

Flow Beverage Corp. (TSX:FLOW; OTCQX:FLWBF) (“Flow” or the “Company”) today announced it has completed the previously announced additional non-brokered private placement of 5,577,000 subordinate voting shares (“SV Shares”) at a price of $0.28 per SV Share to RI Flow LLC (the “Investor”) for gross proceeds of $1,561,560 (the “Additional Offering”), following the initial closing on January 30, 2024 of the non-brokered private placement of 6,473,000 SV Shares at a price of $0.28 per SV Share to the Investor for gross proceeds of $1,812,440 (the “Initial Offering”).

Key Points: 
  • Flow Beverage Corp. (TSX:FLOW; OTCQX:FLWBF) (“Flow” or the “Company”) today announced it has completed the previously announced additional non-brokered private placement of 5,577,000 subordinate voting shares (“SV Shares”) at a price of $0.28 per SV Share to RI Flow LLC (the “Investor”) for gross proceeds of $1,561,560 (the “Additional Offering”), following the initial closing on January 30, 2024 of the non-brokered private placement of 6,473,000 SV Shares at a price of $0.28 per SV Share to the Investor for gross proceeds of $1,812,440 (the “Initial Offering”).
  • The Investor is affiliated with NFS Leasing Canada Ltd., a lender to Flow, and its founder Clifford L. Rucker.
  • The total proceeds raised from the Initial Offering and the Additional Offering are $3,374,000.
  • The gross proceeds from the Additional Offering will be used by the Company for working capital and general corporate purposes.

Alzheon to Present Biomarker, Brain Preservation, and Clinical Results from Pivotal Program of Oral ALZ-801/Valiltramiprosate at International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

Retrieved on: 
Tuesday, February 27, 2024

“The new treatment landscape for Alzheimer’s disease is beginning to take shape, and Alzheon’s simplified approach has an opportunity to transform the standard of care and improve access to treatment for Alzheimer’s patients.

Key Points: 
  • “The new treatment landscape for Alzheimer’s disease is beginning to take shape, and Alzheon’s simplified approach has an opportunity to transform the standard of care and improve access to treatment for Alzheimer’s patients.
  • ALZ-801’s efficacy data and favorable safety profile, showing no increased risk of vasogenic edema, underscore the differentiated clinical profile of our treatment,” said Martin Tolar, MD, PhD, Founder, President, and CEO of Alzheon.
  • Results from our pivotal APOLLOE4 Phase 3 trial will set the stage for the potential NDA filing this year and commercial launch in 2025.”
    Alzheon presentations include two posters and two symposium presentations.
  • If the results of our study are positive, we will be moving quickly to bring an oral option to Alzheimer’s patients and their families,” said John Hey, PhD, Chief Scientific Officer.

Amped Fitness® Set to Electrify the DFW Metro with Their First Texas Location

Retrieved on: 
Thursday, March 7, 2024

RICHARDSON, Texas, March 7, 2024 /PRNewswire/ -- Amped Fitness®, the high-energy gym brand known for its blue light aesthetic and positive culture, is proud to announce its very first location in Texas.

Key Points: 
  • RICHARDSON, Texas, March 7, 2024 /PRNewswire/ -- Amped Fitness®, the high-energy gym brand known for its blue light aesthetic and positive culture, is proud to announce its very first location in Texas.
  • This new Amped Fitness® location is set to make its grand debut in Richardson, TX, marking the brand's 25th corporate-owned location.
  • Located at 110 W Campbell Rd, Unit 100, Richardson, TX, Amped Fitness® Richardson is strategically situated to cater to the fitness needs of residents in the greater DFW metro.
  • Spanning an impressive 38,000 square feet, Amped Fitness® Richardson promises to bring something new to the DFW area, offering a state-of-the-art facility and top-of-the-line equipment.

Planet 13 Announces Closing of Public Offering of Units

Retrieved on: 
Thursday, March 7, 2024

LAS VEGAS, March 7, 2024 /PRNewswire/ - Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) ("Planet 13" or the "Company"), today announced the closing of its previously announced underwritten public offering (the "Offering") for total gross proceeds to the Company of approximately US$11.3 million.

Key Points: 
  • LAS VEGAS, March 7, 2024 /PRNewswire/ - Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) ("Planet 13" or the "Company"), today announced the closing of its previously announced underwritten public offering (the "Offering") for total gross proceeds to the Company of approximately US$11.3 million.
  • Pursuant to the Offering, the Company issued and sold 18,750,000 units of the Company (the "Units") at a public offering price of US$0.60 per Unit.
  • Canaccord Genuity acted as sole book-running manager of the Offering on behalf of a syndicate of underwriters which includes Beacon Securities Limited.
  • The final prospectus supplement relating to the Offering was filed with the SEC and is available on the SEC's website at www.sec.gov .

NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT

Retrieved on: 
Wednesday, March 6, 2024

There is an offering document relating to the Offering that can be accessed under the Company's profile at www.sedarplus.ca and at www.nanalysis.com .

Key Points: 
  • There is an offering document relating to the Offering that can be accessed under the Company's profile at www.sedarplus.ca and at www.nanalysis.com .
  • Prospective investors should read this offering document before making an investment decision.
  • The Company will also be simultaneously conducting a concurrent brokered "best efforts" prospectus exempt offering of Units of the Company, on the same terms as the Offering, for gross proceeds of up to approximately $1,000,000 by way of a private placement.
  • Certain insiders of the Company may participate in the Concurrent Offering.

Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study

Retrieved on: 
Tuesday, March 5, 2024

HERZLIYA, Israel and CALGARY, Alberta, March 5, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery technologies using CBD for the pharmaceutical and biotechnology industries, is pleased to announce the following:

Key Points: 
  • In the Company's latest study, CBD was found to be in the brains of both mice and rabbits weeks after LPT-CBD was subcutaneously injected to them.
  • These results show a strong correlation between the prolonged blood exposure of CBD and its brain distribution.
  • Sufficient exposure of CBD in the brain is the hallmark of CBD therapy associated with various neurological conditions.
  • The fact that LPT-CBD successively delivers CBD to the brain in a long-lasting manner opens a big venue for the treatment of various neurological disorders.

Vogtle Unit 4 connects to electric grid for the first time

Retrieved on: 
Friday, March 1, 2024

ATLANTA, March 1, 2024 /PRNewswire/ -- Georgia Power announced today that Unit 4 at the Vogtle nuclear expansion project near Waynesboro, Georgia, has achieved another major milestone in startup testing by generating electricity and successfully synchronizing and connecting to the electric grid for the first time. This milestone follows initial criticality, reached on February 14, when operators safely started the nuclear reaction inside the reactor, generating nuclear heat to produce steam.

Key Points: 
  • Connecting to the electric grid is part of ongoing startup testing for Vogtle Unit 4.
  • Once all startup testing is successfully completed and the unit is available for reliable dispatch, Vogtle Unit 4 will enter commercial operation.
  • Vogtle Unit 3 entered commercial operation on July 31, 2023, ( read more ) and is providing safe, reliable, emission-free energy to Georgia today.
  • Southern Nuclear is operating the new units on behalf of the co-owners: Georgia Power, Oglethorpe Power, MEAG Power and Dalton Utilities.